Cargando…

How much do rheumatologists and orthopaedists doctors’ modalities impact the cost of arthritis in Cyprus?

BACKGROUND: Osteoarthritis is one of the primary causes of long-term functional disability. With an estimated 13.5 % prevalence in the general population contributes to a significant financial burden both for patients and healthcare systems. The purpose of this research is to highlight the direct an...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrioti, Despena, Kyprianou, Kypros, Charalambous, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535390/
https://www.ncbi.nlm.nih.gov/pubmed/26268588
http://dx.doi.org/10.1186/s12891-015-0643-x
_version_ 1782385599558189056
author Andrioti, Despena
Kyprianou, Kypros
Charalambous, George
author_facet Andrioti, Despena
Kyprianou, Kypros
Charalambous, George
author_sort Andrioti, Despena
collection PubMed
description BACKGROUND: Osteoarthritis is one of the primary causes of long-term functional disability. With an estimated 13.5 % prevalence in the general population contributes to a significant financial burden both for patients and healthcare systems. The purpose of this research is to highlight the direct annual cost of the disease to the private healthcare sector of Nicosia. METHODS: A questionnaire based on Greek and international research was completed between 10/1/2012 and 11/30/2012, with a sample of 20 doctors specialists in orthopaedics and rheumatology (50 % of practising physicians in the private sector). An assessment of the annual cost of medical procedures and tests, pharmacologic therapies (modalities) and supplies per patient followed, based on current costs. Direct costs were assessed through the micro-costing “bottom-up” approach. We isolated and separately priced the original diagnosis, followed by each stage of the disease. RESULTS: The cost for the six predominant medical tests to establish a diagnosis and exclude mainly RA such as ESR, CPR, and X-ray as well as a physician’s office visit was 150€ per patient. The average direct cost per patient during stages 1, 2 and 3 of the disease was 280.54€, 1,834.64€ and 5,641.72€ annually, respectively, with an annual average of 2,573€ per patient. CONCLUSIONS: Even though during the period of the study, the country had not yet established clinical guidelines, the participating physicians followed international practices. Significant rise in the cost in each stage of the disease was found, with additional increases in the following years as a result of the expected increased prevalence of the disease. It is noted here that uninsured patients, as well as those who qualified for free medical care, they seek these services in the private sector, and had to pay out of pocket money for examination and treatment. These patients, thus, contended with a serious financial burden. Therefore, it is important to inform them very extensively regarding evidence-based management of the disease to aid them in coping with this chronic illness.
format Online
Article
Text
id pubmed-4535390
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45353902015-08-14 How much do rheumatologists and orthopaedists doctors’ modalities impact the cost of arthritis in Cyprus? Andrioti, Despena Kyprianou, Kypros Charalambous, George BMC Musculoskelet Disord Research Article BACKGROUND: Osteoarthritis is one of the primary causes of long-term functional disability. With an estimated 13.5 % prevalence in the general population contributes to a significant financial burden both for patients and healthcare systems. The purpose of this research is to highlight the direct annual cost of the disease to the private healthcare sector of Nicosia. METHODS: A questionnaire based on Greek and international research was completed between 10/1/2012 and 11/30/2012, with a sample of 20 doctors specialists in orthopaedics and rheumatology (50 % of practising physicians in the private sector). An assessment of the annual cost of medical procedures and tests, pharmacologic therapies (modalities) and supplies per patient followed, based on current costs. Direct costs were assessed through the micro-costing “bottom-up” approach. We isolated and separately priced the original diagnosis, followed by each stage of the disease. RESULTS: The cost for the six predominant medical tests to establish a diagnosis and exclude mainly RA such as ESR, CPR, and X-ray as well as a physician’s office visit was 150€ per patient. The average direct cost per patient during stages 1, 2 and 3 of the disease was 280.54€, 1,834.64€ and 5,641.72€ annually, respectively, with an annual average of 2,573€ per patient. CONCLUSIONS: Even though during the period of the study, the country had not yet established clinical guidelines, the participating physicians followed international practices. Significant rise in the cost in each stage of the disease was found, with additional increases in the following years as a result of the expected increased prevalence of the disease. It is noted here that uninsured patients, as well as those who qualified for free medical care, they seek these services in the private sector, and had to pay out of pocket money for examination and treatment. These patients, thus, contended with a serious financial burden. Therefore, it is important to inform them very extensively regarding evidence-based management of the disease to aid them in coping with this chronic illness. BioMed Central 2015-08-14 /pmc/articles/PMC4535390/ /pubmed/26268588 http://dx.doi.org/10.1186/s12891-015-0643-x Text en © Andrioti et al. 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Andrioti, Despena
Kyprianou, Kypros
Charalambous, George
How much do rheumatologists and orthopaedists doctors’ modalities impact the cost of arthritis in Cyprus?
title How much do rheumatologists and orthopaedists doctors’ modalities impact the cost of arthritis in Cyprus?
title_full How much do rheumatologists and orthopaedists doctors’ modalities impact the cost of arthritis in Cyprus?
title_fullStr How much do rheumatologists and orthopaedists doctors’ modalities impact the cost of arthritis in Cyprus?
title_full_unstemmed How much do rheumatologists and orthopaedists doctors’ modalities impact the cost of arthritis in Cyprus?
title_short How much do rheumatologists and orthopaedists doctors’ modalities impact the cost of arthritis in Cyprus?
title_sort how much do rheumatologists and orthopaedists doctors’ modalities impact the cost of arthritis in cyprus?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535390/
https://www.ncbi.nlm.nih.gov/pubmed/26268588
http://dx.doi.org/10.1186/s12891-015-0643-x
work_keys_str_mv AT andriotidespena howmuchdorheumatologistsandorthopaedistsdoctorsmodalitiesimpactthecostofarthritisincyprus
AT kyprianoukypros howmuchdorheumatologistsandorthopaedistsdoctorsmodalitiesimpactthecostofarthritisincyprus
AT charalambousgeorge howmuchdorheumatologistsandorthopaedistsdoctorsmodalitiesimpactthecostofarthritisincyprus